XML 19 R8.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements Of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Cash flows from operating activities:    
Net income $ 32,035 $ 22,468
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 4,855 4,613
Net amortization of premiums on securities 1,931 2,473
Provision for loan losses 5,050 9,415
Share-based compensation 1,097 885
Deferred income tax benefit (2,979) (527)
Proceeds from sale of loans held for sale 20,906 9,439
Originations of loans held for sale (20,824) (10,526)
Income on company owned life insurance (1,333) (1,367)
Net gain on sale of loans held for sale (530) (270)
Net loss (gain) on investment securities 88 (600)
Net gain on other assets (49) (25)
Goodwill impairment   1,575
Decrease (increase) in other assets 6,549 (874)
Increase (decrease) in other liabilities 4,013 (1,266)
Net cash provided by operating activities 50,809 35,413
Cash flows from investing activities:    
Purchases of available for sale securities   (86,434)
Purchases of held to maturity securities (24,919) (70,610)
Proceeds from principal payments, maturities and calls on available for sale securities 24,693 29,291
Proceeds from principal payments, maturities and calls on held to maturity securities 80,445 74,205
Proceeds from sales of securities available for sale 27,238 49,424
Net loan originations (259,677) (282,455)
Purchases of company owned life insurance, net of proceeds received (7) (7)
Proceeds from sales of other assets 460 189
Purchases of premises and equipment (1,999) (6,966)
Cash consideration paid for acquisition, net of cash acquired (4,447) (676)
Net cash used in investing activities (158,213) (294,039)
Cash flows from financing activities:    
Net increase in deposits 275,555 286,286
Net decrease in short-term borrowings (138,000) (20,700)
Repurchases of preferred stock   (6)
Proceeds from issuance of common stock   29,664
Purchases of common stock for treasury (113) (148)
Proceeds from stock options exercised 320 413
Cash dividends paid to common and preferred shareholders (12,222) (10,322)
Net cash provided by financing activities 125,540 285,187
Net increase in cash and cash equivalents 18,136 26,561
Cash and cash equivalents, beginning of period 99,195 71,277
Cash and cash equivalents, end of period $ 117,331 $ 97,838